| miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis CH Liu, J Ampuero, A Gil-Gómez, R Montero-Vallejo, Á Rojas, ... Journal of hepatology 69 (6), 1335-1348, 2018 | 146 | 2018 |
| Effect of quercetin on hepatitis C virus life cycle: from viral to host targets Á Rojas, JA Del Campo, S Clement, M Lemasson, M García-Valdecasas, ... Scientific Reports 6 (1), 31777, 2016 | 110 | 2016 |
| Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry I Medina-Caliz, M Garcia-Cortes, A Gonzalez-Jimenez, MR Cabello, ... Clinical Gastroenterology and Hepatology 16 (9), 1495-1502, 2018 | 109 | 2018 |
| Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry C Stephens, M Robles-Diaz, I Medina-Caliz, M Garcia-Cortes, ... Journal of hepatology 75 (1), 86-97, 2021 | 93 | 2021 |
| Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy JA Del Campo, M García-Valdecasas, A Gil-Gómez, Á Rojas, P Gallego, ... PloS one 13 (1), e0191805, 2018 | 43 | 2018 |
| BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection? A Darwich, C Pozzi, G Fornasa, M Lizier, E Azzolini, I Spadoni, F Carli, ... EMBO molecular medicine 14 (5), e15326, 2022 | 34 | 2022 |
| Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study R Muñoz-Hernández, J Ampuero, R Millán, A Gil-Gómez, Á Rojas, ... Clinical and translational gastroenterology 11 (8), e00203, 2020 | 28 | 2020 |
| Diagnostic accuracy of SCCA and SCCA‐IgM for hepatocellular carcinoma: A meta‐analysis CH Liu, A Gil‐Gómez, J Ampuero, M Romero‐Gómez Liver International 38 (10), 1820-1831, 2018 | 25 | 2018 |
| Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation R Gallego-Durán, J Ampuero, H Pastor-Ramírez, L Álvarez-Amor, ... Scientific Reports 12 (1), 3418, 2022 | 21 | 2022 |
| Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma Á Rojas, A Gil‐Gómez, P de la Cruz‐Ojeda, R Muñoz‐Hernández, ... Liver International 42 (6), 1410-1422, 2022 | 18 | 2022 |
| Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication P Gallego, Á Rojas, G Falcón, P Carbonero, MR García-Lozano, A Gil, ... Food & Function 10 (6), 3758-3767, 2019 | 17 | 2019 |
| Gut–liver axis in nonalcoholic fatty liver disease: The impact of the metagenome, end products, and the epithelial and vascular barriers A Gil-Gómez, P Brescia, M Rescigno, M Romero-Gómez Seminars in liver disease 41 (02), 191-205, 2021 | 15 | 2021 |
| Development and validation of a clinical-genetic risk score to predict hepatic encephalopathy in patients with liver cirrhosis A Gil-Gómez, J Ampuero, Á Rojas, R Gallego-Durán, ... Official journal of the American College of Gastroenterology| ACG 116 (6 …, 2021 | 13 | 2021 |
| Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype Á Rojas, P Gallego, A Gil-Gómez, R Muñoz-Hernández, L Rojas, ... Annals of hepatology 17 (2), 242-249, 2018 | 12 | 2018 |
| Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD J Ampuero, R Gallego-Durán, D Maya-Miles, R Montero, S Gato, A Rojas, ... Journal of Gastroenterology 57 (5), 357-371, 2022 | 10 | 2022 |
| Simple non‐invasive scoring systems and histological scores in predicting mortality in patients with non‐alcoholic fatty liver disease: a systematic review and meta‐analysis CH Liu, J Ampuero, M Pavlides, VWS Wong, JG Fan, L Bai, H Li, DB Wu, ... Journal of Gastroenterology and Hepatology 36 (7), 1754-1768, 2021 | 9 | 2021 |
| Extracellular vesicles as biomarkers in liver disease R Muñoz-Hernández, Á Rojas, S Gato, J Gallego, A Gil-Gómez, MJ Castro, ... International Journal of Molecular Sciences 23 (24), 16217, 2022 | 8 | 2022 |
| Glutaminolysis-ammonia-urea cycle axis, non-alcoholic fatty liver disease progression and development of novel therapies Á Rojas, MR García-Lozano, A Gil-Gómez, M Romero-Gómez, J Ampuero Journal of Clinical and Translational Hepatology 10 (2), 356, 2022 | 8 | 2022 |
| Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy A Gil-Gómez, AI Gómez-Sotelo, I Ranchal, Á Rojas, M García-Valdecasas, ... Revista Española de Enfermedades Digestivas 110 (7), 427-433, 2018 | 8 | 2018 |
| Performance of different biomarkers for the management of hepatocellular carcinoma Á Rojas, Y Sánchez-Torrijos, A Gil-Gómez, CH Liu, C Rodríguez-Rivas, ... Hepatoma Res 4, 31, 2018 | 7 | 2018 |
